Publications by authors named "E P Kozina"

Article Synopsis
  • - The article reviews the anatomy and histopathology of the patellar tendon, focusing on patellar tendinopathy (PT), a chronic injury common in athletes who perform jumping activities.
  • - PT is characterized by degeneration of collagen fibers in the tendon, and its risk factors include involvement in jumping sports, higher jump heights, and training on harder surfaces.
  • - Treatment options range from nonoperative methods like rest and exercises to surgical interventions, including extracorporeal shockwave therapy (ESWT) for patients not improving with conservative care.
View Article and Find Full Text PDF

Introduction: Optimal fixation method between cemented, cementless, and hybrid techniques for total knee arthroplasty (TKA) is still debated. The purpose of this study is to evaluate the clinical outcomes of patients undergoing cemented versus cementless TKA.

Methods: We reviewed 168 patients who underwent a primary TKA at a single academic institution between January 2015 and June 2017.

View Article and Find Full Text PDF

The nicotinamide adenine dinucleotide hydrolase (NADase) sterile alpha toll/interleukin receptor motif containing-1 (SARM1) acts as a central executioner of programmed axon death and is a possible therapeutic target for neurodegenerative disorders. While orthosteric inhibitors of SARM1 have been described, this multidomain enzyme is also subject to intricate forms of autoregulation, suggesting the potential for allosteric modes of inhibition. Previous studies have identified multiple cysteine residues that support SARM1 activation and catalysis, but which of these cysteines, if any, might be selectively targetable by electrophilic small molecules remains unknown.

View Article and Find Full Text PDF

Mutations in a number of genes contribute to development of Parkinson's disease (PD), including several within the LRRK2 gene. However, little is known about the signals that underlie LRRK2-mediated neuronal loss. One clue resides in the finding that the neurodegenerative cascades emanate from signals arising from the peripheral immune system.

View Article and Find Full Text PDF

 Eptacog alfa (activated) is a recombinant activated factor VII (rFVIIa) used for the treatment and prevention of bleeding episodes in patients with congenital hemophilia with inhibitors. Frequent dosing requirements make the use of an automated bolus infusion pump a promising alternative to manual administration.  The objective of this in vitro study was to evaluate the physical and chemical stability of room temperature-stable rFVIIa at 25°C over 24 hours in an automated bolus infusion pump.

View Article and Find Full Text PDF